India's pharmaceuticals regulator has begun inspecting some drug factories across the country, the health ministry said on Tuesday, as it tries to ensure high standards after an Indian company's cough and cold syrups were linked to deaths in Gambia.
India is known as the "pharmacy of the world" and its pharmaceuticals exports have more than doubled over the past decade to $24.5 billion in the past fiscal year.
The deaths of at least 70 children in Gambia has dented the industry's image, though India says the drugs made by New Delhi-based Maiden Pharmaceuticals Ltd were not at fault.
